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We present a method for obtaining long haplotypes, of over 3 kb in length, using a short-read sequencer,
Barcode-directed Assembly for Extra-long Sequences (BAsE-Seq). BAsE-Seq relies on transposing a template-specific
barcode onto random segments of the template molecule and assembling the barcoded short reads into complete
haplotypes. We applied BAsE-Seq on mixed clones of hepatitis B virus and accurately identified haplotypes occurring at
frequencies greater than or equal to 0.4%, with >99.9% specificity. Applying BAsE-Seq to a clinical sample, we obtained
over 9,000 viral haplotypes, which provided an unprecedented view of hepatitis B virus population structure during
chronic infection. BAsE-Seq is readily applicable for monitoring quasispecies evolution in viral diseases.Background
The ability of viruses to escape host immune responses or
develop drug resistance represents a significant challenge
to human health. Successful viral evolution is driven by
high mutation rates that generate genetically diverse pop-
ulations within an infected host, which are referred to as
viral quasispecies [1,2]. Genetic interactions between mu-
tant viruses within a quasispecies have been proposed to
affect the overall fitness of the population through a com-
bination of cooperative and antagonistic effects [3-6]. In
recent years, next-generation DNA sequencing technolo-
gies have been used to perform ultra-deep sequencing of
bulk samples to detect signatures of viral quasispecies by
measuring allele distributions of single nucleotide variants
(SNVs) [7-10] (this approach is hereafter referred to as
'Deep-Seq'). This approach was recently refined through
the development of methods based on redundant sequen-
cing of barcode-tagged or circularized template molecules
to reduce the error rates associated with next-generation
sequencing, enabling the detection of lower frequency
SNVs [11-13]. However, any meaningful attempt to study
intra-quasispecies interactions will require the ability to* Correspondence: quake@stanford.edu; wfburkholder@gmail.com
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unless otherwise stated.determine viral haplotypes (here, 'haplotype' refers to
the set of SNVs that occur on a particular copy of the
viral genome) so that the correlation and co-occurrence of
SNVs within quasispecies can be characterized. Unfortu-
nately, most sequencing platforms are inherently inad-
equate with respect to resolving haplotype information
beyond several hundred base pairs due to limitations on
read length [14], and existing assembly algorithms for
haplotype reconstruction from quasispecies suffer from
poor sensitivity and specificity [15].
There are several possible approaches for determining
haplotypes of viruses with long genomes ('long-range
haplotypes'; >1 kb) using existing sequencing technology.
One possibility is to use a long-read single-molecule se-
quencing platform such as the PacBio RS II or nanopore-
based sequencers. However, the high intrinsic error rate of
the PacBio platform necessitates redundant sequencing
across the same template to obtain an accurate consensus
sequence, thereby substantially decreasing the effective
read length of the technology [16,17]. Sequencers based
on nanopore technology are still in development; the ac-
curacy and scalability of this type of technology are cur-
rently unclear [18,19]. Another possibility for obtaining
long-range haplotypes is to extend the effective single-
molecule read length obtained from short-read platforms.
To that end, several methods have been developed. A
method developed by Hiatt et al. [20] relied on taggingtd. This is an Open Access article distributed under the terms of the Creative
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followed by paired-end sequencing of nested breakpoints
and performing hierarchical local assembly to reconstruct
the template sequence. This method produced 'subassem-
blies' that were only approximately 700 bp in size due to
constraints in the size of molecules that can be efficiently
processed on the sequencer. Schwartz et al. [21] devel-
oped a method that involved stretching long DNA mole-
cules on an Illumina flow cell, followed by in situ library
construction. Sequence reads that originated from the
same molecule were combined by relying on spatial infor-
mation from the flow cell. This method is technically chal-
lenging as it involves customized modification of the
sequencer. Single virion sequences have been obtained
by molecular cloning or by serial dilution of cDNA or
DNA molecules to achieve ≤1 copy per reaction, followed
by a 'primer walking' method using capillary sequencing
to obtain clonal sequences [22-26]. In principle, this ap-
proach can produce high quality haplotypes where se-
quence length will only be limited by technical constraints
in performing molecular cloning and long-range PCR, but
suffers from relatively low throughput due to high cost for
reagents and labor. Several methods have been developed
that rely on physical separation of DNA molecules into
reaction chambers containing one or few molecules using
limiting dilution or microfluidics, and assembling haplo-
types from short reads generated by performing next-
generation sequencing on individual reaction chambers
[27-30]. Using this approach requires independent library
preparation from each reaction chamber, thereby lim-
iting the number of haplotypes that can be obtained
per experiment.
Here, we report a method that obtains long haplotypes
(>3 kilobases) from viral samples using a short-read se-
quencer: BAsE-Seq or Barcode-directed Assembly for
Extra-long Sequences. BAsE-Seq takes advantage of the
low cost-per-base and low error rates of short-read se-
quencing platforms and addresses the limitations of
current methods for extending read lengths. BAsE-Seq
relies on attaching unique molecular barcodes to long
template molecules, followed by transposing the bar-
code to random overlapping segments of the template;
barcode-tagged sequence reads derived from the same
template molecules can be combined to obtain highly ac-
curate haplotype sequences. BAsE-Seq was used to per-
form single virion sequencing of hepatitis B virus (HBV),
which has an approximately 3.2 kb genome and exists as a
quasispecies within its host [31-33]. We first describe
using BAsE-Seq to obtain individual genome sequences
at high accuracy from mixed samples of HBV clones
and demonstrate the assembly of viral haplotypes at
high sensitivity and specificity. Next, we used BAsE-Seq
to obtain the first-time measurement of >9,000 viral hap-
lotypes from a clinical sample. Our method showed goodagreement in SNV and haplotype identification when
compared with Deep-Seq and clonal sequencing, and
allowed us to investigate intra-host phylogenetic structure
of HBV quasispecies during chronic infection.
Results and discussion
Overview of BAsE-Seq
An outline of the BAsE-Seq methodology is shown in
Figure 1a. The basic workflow involves attaching unique
barcodes to full-length HBV genomes, and then con-
structing a library where the barcode is juxtaposed to
random overlapping fragments of its assigned genome.
Barcode assignment is performed using a pair of primers
that contain HBV-specific sequences on their 3′ ends
and universal sequences on their 5′ ends (Figure S1 in
Additional file 1). Subsequently, barcode-tagged genomes
are clonally amplified by PCR using universal primers
and exonuclease-mediated digestion is initiated from the
barcode-distal end to obtain a broad size distribution of
barcode-containing fragments. Next, these fragments are
circularized by intramolecular ligation, which juxtaposes
different regions of the viral genome adjacent to its
assigned barcode. The circularized molecules are used as
a template for random fragmentation and adapter tagging
using Nextera transposomes, followed by PCR enrichment
of the sequencing library to incorporate Illumina-specific
paired-end adapters and enrich for barcode-tagged mole-
cules. The library is loaded on a MiSeq for 2 × 150 bp se-
quencing and a custom sequencing primer is used for the
second read to obtain the barcode sequence.
After sequencing, barcode-containing read pairs are
used to generate a 'bulk consensus' genome by iterative
alignment of read pairs against a HBV reference sequence
from GenBank. Next, aligned read pairs are de-multiplexed
based on barcode identity, and 'individual consensus' ge-
nomes are obtained by extracting the consensus base call
at each position. Finally, SNVs relative to the bulk consen-
sus genome are identified from individual genomes and
used to construct haplotypes (Figure 1b).
Developing BAsE-Seq for single virion sequencing
In this subsection, we will discuss the critical steps of
our protocol and several challenges that were overcome
during the development of BAsE-Seq.
The forward primer used during barcode assignment
contains a string of 20 random nucleotides, which allows
for approximately 1.1 × 1012 possible barcode sequences.
Barcode assignment is performed using two cycles of PCR
on a template containing 106 double-stranded HBV ge-
nomes. This represents an approximately 55,000-fold ex-
cess of possible barcode sequences to template molecules;
each strand of the genome will be uniquely tagged by a
barcode and flanked by universal sequences (Figure S1
in Additional file 1). With this approach, random errors
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Figure 1 Outline of BAsE-Seq methodology. (a) The goal of library preparation is to attach unique barcodes to full-length HBV genomes, and
then juxtapose the assigned barcode to random overlapping fragments of the viral genome. A unique barcode is first assigned to each HBV
genome using PCR. The two barcode assignment primers contain HBV-specific sequences on their 3′ ends, universal sequences (green) on their
5′ ends, and one of the primers also contains a random barcode (blue). Subsequently, barcode-tagged genomes are clonally amplified by PCR
using primers that anneal to Uni-A and Uni-B and that add a biotin label (Bio) to the barcode-proximal end. The barcode-distal end is digested
with exonuclease to obtain a broad size distribution of nested deletion fragments. Barcode-containing fragments are purified using Dynabeads,
and intramolecular ligation of these fragments yields a library of circular molecules in which different regions of each HBV genome are juxtaposed
to its assigned barcode. The circularized molecules are used as a template for random fragmentation and adapter tagging following the Nextera
protocol. During PCR enrichment, a set of primers is used to incorporate Illumina-specific paired-end adapters and enrich for barcode-tagged
molecules during sequencing. (b) Bioinformatics workflow. Barcode-containing read pairs are used to obtain a 'bulk consensus' genome by iterative
alignment of read pairs against a GenBank sequence. Aligned read pairs are de-multiplexed into individual genomes based on barcode identity.
Consensus base calls are extracted to obtain 'individual consensus' genomes and SNVs are identified in each genome to construct haplotypes.
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such as during library preparation or sequencing, can
be removed (Figure S1 in Additional file 1) [13,34]. Hence,
the only errors that will remain are PCR errors that
were incorporated during barcode assignment or system-
atic errors that occurred during library preparation or
sequencing.
There are two steps in BAsE-Seq that are critical for
producing uniform genome coverage: (a) generating de-
letions from the barcode-distal end of each HBV genome
and (b) generating a sequencing library from circularized
molecules. In the former, the goal is to obtain an equi-
molar size distribution of barcode-tagged HBV genomes
containing nested deletions from the barcode-distal
end, as it will expose different regions along the genome
for juxtaposition with the barcode during circularization.This was achieved using a classical approach in which
exonuclease III was used for processive digestion from an
unprotected end (barcode-distal end) of the template
and aliquots were removed at defined time intervals for
S1 nuclease digestion to create blunt ends [35]. In the
latter, an efficient method was required to fragment
circularized molecules and attach sequencing adaptors
onto barcode-containing fragments. To achieve this, we
relied on a transposase-catalyzed method (Illumina) that
is known to introduce slightly higher bias in fragmentation
compared with conventional methods, but offered signifi-
cant advantages in its simplicity and ability to handle low
input material [36].
To generate a suitable HBV template for protocol devel-
opment, we isolated two different HBV clones that con-
tained 17 single nucleotide polymorphisms (SNPs) between
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S1 and S2 in Additional file 1). During the initial phase of
protocol development, we used a 1:1 mixture of Clone-1
and Clone-2 for library preparation in order to assess the
ability of our protocol to generate accurate haplotype se-
quences. Subsequent analysis of sequence data that were
generated from the first round of libraries showed that the
majority of haplotypes were chimeric, i.e., contained SNPs
from both Clone-1 and Clone-2 (data not shown). To iden-
tify the steps in our protocol where molecular chimerism
was occurring, we prepared libraries in which samples de-
rived from Clone-1 and Clone-2 were mixed at different
steps along the protocol. Using this approach, we determined
that chimeric sequences were mostly generated during (a)
the PCR amplification step that occurred immediately after
barcode assignment and (b) the circularization step. Taking
reference from previous studies where it was demon-
strated that PCR-induced chimeras could be reduced by
limiting the number of PCR cycles [37,38], we developed a
real-time PCR assay to monitor the PCR efficiency at this
step and realized that PCRs that were stopped during the
log-linear phase of amplification produced significantly
less chimeric sequences. This led us to develop a two-
stage PCR protocol to amplify barcode-tagged HBV ge-
nomes (further described in Appendix B in Additional
file 2) that minimized the formation of PCR-induced chi-
meras and provided enough PCR products to continue
with library preparation. To identify reaction conditions
for double-stranded DNA circularization that maximized
intramolecular ligation and minimized intermolecular
ligation (which will result in the formation of chimeric se-
quences), we mixed two sub-genomic HBV sequences -
each approximately 1 kb long - at equimolar amounts and
used them as template for circularization. We developed a
quantitative PCR assay (further described in Appendix C
in Additional file 2) to measure the abundance of junc-
tions formed by inter- or intra-molecular ligation. This
assay allowed us to screen a large number of reaction
conditions and identified two key parameters that were
critical for optimal circularization: reaction volume and
temperature. Notably, a significantly higher rate of intra-
molecular ligation (approximately 5%) was achieved by in-
creasing the reaction volume to 45 ml and decreasing the
reaction temperature to 10°C. Ultimately, a combination
of optimized conditions at both steps - PCR amplification
and circularization - allowed us to produce haplotype se-
quences with minimal chimerism (as presented below).
Validation of BAsE-Seq with mixed hepatitis B virus clones
To assess the accuracy and sensitivity of BAsE-Seq in
performing single virion sequencing on HBV, we mixed
Clone-1 and Clone-2 at unequal ratios (1:9 and 1:99) prior
to barcode assignment and library preparation, yielding
two BAsE-Seq libraries: Lib_1:9 and Lib_1:99. Each librarywas sequenced on a single run on the MiSeq, producing 6
to 8 million read pairs that could be aligned concor-
dantly to the bulk consensus genome (Table 1; Figure
S2 in Additional file 1). Subsequently, each library was
analyzed using the 'bulk' approach or the 'individual' gen-
ome approach. In the bulk analysis, barcode information
was ignored, i.e., sequence reads were not de-multiplexed,
and the aligned read pairs were analyzed using a typical
pipeline for Deep-Seq in which BAM files were used as in-
put for variant calling using LoFreq [39,40]. In the individ-
ual genome analysis, aligned read pairs associated with
unique barcodes were analyzed separately as described
earlier (Figure 1b).
At the individual genome level, average per-base coverage
was high (>50 unique reads) for both libraries across the
majority of bases in the genome (Figure S3 and Table S3 in
Additional file 1). We obtained 2,390 and 3,673 high quality
genomes - ≥4 unique reads per base position across ≥85%
of the genome - from Lib_1:9 and Lib_1:99, respectively
(Table 1). These high quality genomes were used in down-
stream analysis for SNV identification, error analysis, and
haplotype analysis.
The bulk analysis identified all 17 true SNVs at an
average minor allele frequency (MAF) of 14.3 ± 1.9% in
Lib_1:9 and 15 out of 17 true SNVs at an average MAF
of 0.712 ± 0.264% in Lib_1:99. In comparison, the indi-
vidual genome analysis identified all 17 true SNVs in
both libraries, at an average MAF of 11.4 ± 0.2% in
Lib_1:9 and 0.394 ± 0.026% in Lib_1:99 (Figure 2). Since
the true consensus sequence is known and the error rate
of plasmid replication is extremely low (approximately
5 × 10-10) [41], variants at non-SNP positions can be
classified as errors generated by our protocol; the overall
error rate was approximately seven-fold lower in the indi-
vidual genome analysis (Table 1). Furthermore, the highest
per-base error rate is approximately 0.2% in the individual
genome analysis, which is approximately nine-fold lower
compared with the bulk analysis (Table 1). These results
indicate that our consensus base-calling approach using
barcodes can substantially reduce the error rate of next-
generation sequencing, thereby increasing the sensitivity
and specificity of detecting SNVs occurring at ≤2% fre-
quency (Table 1 and Figure 2). Further, using barcodes to
tag individual genomes provides more precise estimation
of SNV frequencies, as was evident in lower standard devi-
ations in SNV frequencies observed in the individual gen-
ome analysis.
Based on the fidelity of the Long PCR Enzyme Mix re-
ported by the manufacturer (7.3 × 10-6 errors per nucleo-
tide per PCR cycle), the expected error rate during barcode
assignment is approximately 0.0015% - approximately one
error in 22 HBV genomes - which sets the expected error
rate for BAsE-Seq. However, the error rate for both Lib_1:9
and Lib_1:99 is approximately four-fold higher (Table 1).
Table 1 Summary statistics from BAsE-Seq and Deep-Seq of hepatitis B virus
Lib_1:9 Lib_1:99 S7.1
Read-pairs 14,352,128 17,083,497 42,997,995 8,197,770
Library BAsE-Seq BAsE-Seq BAsE-Seq Deep-Seq
Type of sample Mixed clone Mixed clone Internal standard Patient Patient
Pass-filter read pairsa 6,751,411 (47%) 8,816,934 (52%) 545,960 (1%) 26,066,408 (61%) 6,351,796 (77%)
Concordantly alignedb 6,027,421 (89%) 8,150,721 (92%) 496,356 (91%) 23,366,358 (90%) 4,261,572 (67%)
High quality genomes 2,390c 3,673c 345d 12,444d
Type of analysis Bulk Individual Bulk Individual Individual Individual
Median per-base coverage depth 333,677 86 470,036 63 38 45 131,492
True SNVs detected 17 /17 17/17 15/17 17/17 68
SNVs detected 308
Errors detected 522 218 328 257 11
Highest per-base error 1.91% 0.202% 2.14% 0.231% 0.69%
Overall error 0.0524% 0.00674% 0.0324% 0.00541% 0.00214%
Each BAsE-Seq library was analyzed using the 'bulk' approach, i.e., without de-multiplexing by barcode identity, or the 'individual' approach, i.e., sequence reads
associated with unique barcodes were analyzed separately. True SNVs in S7.1 were identified by BAsE-Seq as those that occurred at >0.69% frequency.
aRead pairs after removal of adaptor and/or universal sequences. For BAsE-Seq libraries, this only includes read pairs that carry a barcode.
bBoth reads in a pair were aligned in the expected orientation.
c≥ 4 unique reads per base position across ≥85% of the genome.
d≥ 4 unique reads per base position across ≥50% of the genome.
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libraries have a significant overlap with regards to base
position (P < 4e-14, Fisher’s exact test), which suggests
that some of the errors were not removed by our ap-
proach because they were introduced systematically. It
is also likely that the higher than expected error rate
could be because the PCR polymerase used during
barcode assignment has a higher error rate than is re-
ported by the manufacturer.
For both Lib_1:9 and Lib_1:99, the observed frequencies
of the Clone-1 and Clone-2 haplotypes were very close to
the expected frequencies (Table 2). In addition to the
expected haplotype sequences, two haplotype sequences
were detected in each library that differed from the
sequences of the two clones used for library preparation.
These haplotypes could be the result of molecular chi-
meras that formed during library preparation. Alter-
natively, given their low frequency (≤0.05%) and the
presence of only one discordant SNV in each haplotype
sequence, they could be the result of errors in individual
genome sequences. Taken together, these results indicate
that BAsE-Seq generates highly sensitive and accurate
SNV calls and haplotypes from viral samples.
Evaluation of BAsE-Seq on a patient sample
To evaluate the performance of BAsE-Seq on a clinical
sample, BAsE-Seq and Deep-Seq libraries were generated
using viral DNA isolated from a chronic hepatitis B
patient. This patient sample is hereafter referred to as
‘S7.1’. Sequence reads from the Deep-Seq library were
used to generate a bulk consensus genome for S7.1, andsubsequent alignment to this bulk consensus genome pro-
duced a median per-base coverage depth of 131,492 reads
(Table 1; Figure S4 in Additional file 1). We identified 308
SNVs from the Deep-Seq library, ranging in frequency
from 0.2% to 47% (Table 1 and Figure 2e). In the BAsE-
Seq library, we used an internal standard in order to esti-
mate error frequencies during library preparation and
sequencing; the internal standard acts as a control for er-
rors observed in the library that it was prepared from. We
prepared the internal standard by assigning barcodes
separately to HBV Clone-2; these barcodes contained a
two-base insertion that allowed us to distinguish them
from patient-specific viral genomes. After barcode assign-
ment, the internal standard was mixed with patient-
specific viral genomes and used to build a BAsE-Seq
library. Among 345 high quality genomes derived from
the internal standard, the highest per-base error rate was
0.69%, which we termed the 'baseline error frequency' for
the library. Using the baseline error frequency as a thresh-
old below which a SNV might be due to an error and
above which a SNV was treated as a true SNV, we identi-
fied 68 true SNVs among the 12,444 high quality genomes
assembled from S7.1 (Table 1). The SNVs were evenly dis-
tributed across the genome and had a large frequency
range: 17 SNVs occurred below 1% frequency, 24 SNVs
occurred between 1% and 10% frequency, and 27 SNVs
occurred above 10% frequency (Figure 2f ). Although
our pipeline should preclude SNVs occurring above
50% frequency, one SNV was identified by BAsE-Seq
at approximately 62% frequency because the bulk consen-
sus genome was generated using sequence reads from
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Figure 2 SNVs in BAsE-Seq and Deep-Seq libraries. (a-d) SNVs in BAsE-Seq libraries Lib_1:9 and Lib_1:99 were identified as true SNVs (red
diamonds) or errors (blue dots) using the 'bulk' approach (a,c) or the 'individual' approach (b,d). The frequency of each SNV (y-axis) is
plotted against base position in the consensus sequence (x-axis). Additional information is also provided in Tables 1 and 3. (e,f) SNVs
from S7.1 were identified using Deep-Seq and BAsE-Seq. The BAsE-Seq library contained an internal standard that was used to calculate
the error-free frequency cutoff for the library; hence, only error-free SNVs are shown in the BAsE-Seq analysis of S7.1. (g) The frequency
of SNVs detected in the BAsE-Seq library (y-axis) is plotted against the frequency of SNVs detected in the Deep-Seq library (x-axis). All 68
error-free SNVs identified by BAsE-Seq were also identified by Deep-Seq (Pearson correlation coefficient = 0.94).
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Table 2 Haplotypes identified by BAsE-Seq in Lib_1:9 and
Lib_1:99
Haplotypesa
Lib_1:9 Lib_1:99
Individualb Bulkc Individualb Bulkc
........................................................ 2,118 88.6% 85.7% 3,656 99.5% 99.3%
ACACTAAATTTAAACAG 270 11.3% 14.3% 14 0.4% 0.7%
....C................................................ 1 0.04% 0% 1 0.03% 0%
ACACTAAATTTAAA...AG 1 0.04% 0% 0 0% 0%
....................A................................ 0 0% 0% 2 0.05% 0%
Total 2,390 100% 100% 3,673 100% 100%
aHaplotypes observed in individual genomes. The major allele (Clone-2) is
represented by a period and the minor allele (Clone-1) is represented by the
base at that position (Table S2 in Additional file 2).
bHaplotype frequencies observed in individual genomes.
cAverage allele frequency of SNPs from 'bulk' analysis.
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quency just below 50%.
There was good agreement between BAsE-Seq and
Deep-Seq in SNV identification: all 68 true SNVs identi-
fied by BAsE-Seq were also found by Deep-Seq and SNV
frequencies were highly correlated between both methods
(Figure 2g). Five SNVs at >10% frequency were detected
by Deep-Seq but were missed by BAsE-Seq because these
SNVs were all located within 60 bp of the BAsE-Seq
primer binding sites, where per-base coverage using BAsE-
Seq was significantly lower (Figure 2g). All of the remainingTable 3 Comparison of haplotypes observed over a 367 bp re
SNV positiona 118 119 192 258
Consensus baseb T G C G
Variant base G A T C
Deep-Seq frequency (%) 19.6 45.2 46.7 47.3
BAsE-Seq frequency (%) 18.5 61.5 39.9 40.6
Haplotypesc
. A . .
. . T C
G . T C
. . T C
G . T C
. . . .
G A T C
. A . .
. . T .
G . . C
. A T C
Unique haplotypes
Total observed haplotypes
aSNVs identified by all three methods - Sanger sequencing of clones, Deep-Seq and
bBase call in the bulk consensus genome.
cA period on the haplotype indicates that the position carries the consensus base. SSNVs that were only detected by Deep-Seq occurred at
frequencies <1.4% (Figure 2g). Among these SNVs, 217
were also found in the BAsE-Seq data but occurred below
the baseline error frequency used as a cutoff; it is unclear
whether these are true SNVs or errors. The remaining 18
SNVs were not found in the BAsE-Seq data despite good
per-base coverage, and are likely to be errors specific to
Deep-Seq.
To validate the accuracy of haplotypes observed by
BAsE-Seq in S7.1, 20 sub-genomic clones containing the
pre-core and basal core promoter region were isolated.
Capillary sequencing was performed, which detected a
total of five SNVs and five unique haplotypes across a
367 bp region (Table 3). In total, BAsE-Seq analysis of
S7.1 identified 2,555 haplotypes with a 100% SNV calling
rate across this region. Ten unique haplotypes were de-
tected; four of these haplotypes were also observed in the
sequenced clones, which includes the three most fre-
quently observed haplotypes and a haplotype that was de-
tected at approximately 0.08% frequency in BAsE-Seq
(Table 3). These results indicate that BAsE-Seq is capable
of highly sensitive, accurate and quantitative identification
of single virion sequences from a clinical sample.
Analysis of haplotypes in the patient sample
Of the 68 SNVs identified by BAsE-Seq in S7.1, 56 confer
changes in amino acid sequence, while the other 12 aregion in S7.1
484
C
A
4.5
4.2
Observed in clones Observed in BAsE-Seq
. 10 (50%) 1,588 (62%)
. 2 (10%) 428 (17%)
. 5 (25%) 403 (16%)
A 0 65 (3%)
A 0 27 (1%)
. 0 24 (1%)
. 0 14 (0.5%)
A 1 (5%) 2 (0.08%)
. 0 2 (0.08%)
. 0 2 (0.08%)
. 2 (10%) 0
5 10
20 2,555
BAsE-Seq.
NVs are represented by the identity of the variant base.
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the non-synonymous variants, seven are nonsense muta-
tions (one in the open reading frame (ORF) for the HBV
C protein, one in the ORF for X protein, and five in the
ORF for S protein) and one is a mutation in the stop-codon
of the C gene that extends the ORF by six amino acids
(Table S4 in Additional file 1); most of these mutations have
been previously described [42-44] or exist in sequences
from GenBank. Five of the nonsense mutations are located
near the end of their ORFs and consequently may reduce
or alter the expression or activity of the expressed proteins
rather than abolishing expression altogether.
We identified 236 unique haplotypes from among the
9,072 haplotypes assembled from S7.1 that had a 100%
call rate across all SNV positions; these haplotypes were
detected at frequencies ranging from 0.01% to 8.3%. The
actual number of unique haplotypes in the sample is
likely to be higher because the library was not sequenced
to saturation (Table 3) and any true SNVs present below
the baseline error frequency cutoff were not included in
the analysis (Table 1). A phylogenetic analysis revealed the
existence of at least six distinct clades (Figure 3). Each
clade consisted of at least one haplotype sequence that oc-
curred at relatively high frequency and whose sequence is
close to the common ancestor of the clade (for example,
haplotype 1 in clade 2 and haplotype 5 in clade 4). Some
clades have relatively deep branching patterns, which may
indicate that they are evolving faster (for example, clade 6).
Notably, five out of six clades contained at least one amino
acid mutation that is likely to confer a fitness advantage
(Figure 3). For instance, haplotypes in clade 4 contain
one or more of the following mutations: nonsense muta-
tions (sS235-stop and sW248-stop; refer to Table S4 in
Additional file 1 for an explanation of residue numbering)
that yield truncated surface proteins that are missing
the 'a' determinant, i.e., the immunodominant region
of HBsAg [45], and a mutation that results in immune es-
cape [46,47] (sP294T, usually referred to as sP120T, with
respect to the small S protein). Also, another immune es-
cape mutation, sQ303R [46,47] (usually referred to as
sQ129R), co-exists on the same haplotype with sP294T in
clades 1, 2 and 6 and comprises approximately 50% of
all haplotypes in the quasispecies. Finally, the sL360H
mutation found in clade 5 has been predicted to dis-
rupt homo-dimerization of the S protein [48]. Taken to-
gether, the phylogenetic structure of viral quasispecies in
this patient is consistent with a scenario where common
haplotypes in the founder HBV population gave rise to
sub-populations that evolved adaptive mutations required
for viral persistence.
Intriguingly, a nonsense mutation (cQ181-stop) and a
stop codon mutation (c-stop183QYSLDT) in the C gene
are both associated with clade 2 (Figure 3), and co-exist on
approximately 93% of haplotypes that carry a mutation ateither position in the quasispecies (Table S5 in Additional
file 1). Furthermore, a closer inspection of all haplotypes
among the S7.1 quasispecies shows that both immune es-
cape mutations described above - sP294T and sQ303R -
are found on approximately 98% of haplotypes that
contain both cQ181-stop and c-stop183QYSLDT but are
only found on approximately 40% of haplotypes that are
wild type at cQ181 and c-stop183 (Table S5 in Additional
file 1). The co-occurrence of these four mutations on the
same haplotypes strongly suggests that cQ181-stop and
c-stop183QYSLDT may have arisen on an ancestral gen-
ome that already carried the sP294T and sQ303R mutations.
A plausible scenario is that cQ181-stop, which removes the
last two amino acids from the core protein, may have
arisen as an intragenic suppressor of c-stop183QYSLDT
to restore the fitness advantage conferred on this haplo-
type by the immune escape mutations. Importantly, these
mutations are separated by >1.3 kb and their occurrence
with respect to one another cannot be resolved without
long-range haplotype information.
Future applications and possible improvements to BAsE-Seq
The current manifestation of BAsE-Seq contains a region
of approximately 60 bp at each end of the HBV genome
where potential SNVs are missed because per-base cover-
age is significantly lower. This can be resolved by modifying
the exonuclease digestion step, such as having additional
time points, to allow these regions to be included in li-
brary preparation. With some modifications to the proto-
col that will involve the design of new primer sets, we
anticipate that BAsE-Seq can be used to study other DNA
viruses (for example, human papillomavirus) or low com-
plexity but genetically heterogeneous regions (for ex-
ample, B-cell or T-cell receptor sequences). However,
further optimization of several steps in the BAsE-Seq
protocol - genome amplification, exonuclease digestion
and circularization steps - may be required to achieve lon-
ger haplotype sequences (>4 kb). By modifying the proto-
col to attach a barcode during reverse transcription,
BAsE-Seq can also be applied to study RNA viruses (for
example, HIV-1), or used to estimate the relative abun-
dance of transcript isoforms. Taking into account the
technical constraints in performing reverse transcription
efficiently across long RNA templates, the future applica-
tion of BAsE-Seq may be restricted to studying sub-
genomic regions of large RNA viruses. Finally, given the
input requirements of BAsE-Seq (106 HBV genomes), im-
provements to the efficiency of barcode assignment and
genome amplification will be necessary in order to study
clinical samples with low viral load.
Alternative approaches to BAsE-Seq
Recently, two methods using strategies similar to BAsE-
Seq were published. The first method - called Tile-Seq -
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Figure 3 Phylogenetic analysis of intra-host viral quasispecies. A phylogenetic analysis of HBV haplotypes identified by BAsE-Seq identified
six distinct clades (numbered 1 to 6) in S7.1. The black scale bar represents the expected number of substitutions per site and the blue scale bar
represents the frequency at which a particular haplotype was identified in the sample. Amino acid changes that are found in ≥70% of clade
members are listed within each clade. Amino acid changes that are unique to each clade are listed with an asterisk. Five out of six clades contain
at least one amino acid change (red) that is likely to confer the ability to escape immune detection.
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produce haplotype information because individual tem-
plate molecules were not tagged separately for down-
stream analysis [49]. Wu et al. [50] developed a method
that obtained approximately 1.3 kb viral haplotypes, but
relied on performing multiple nested PCRs to generate de-
fined deletions of the initial template; this approach re-
quired a priori knowledge of the entire template sequence
and its specificity in haplotype reconstruction was not
demonstrated, thus raising concerns over the presence of
chimeric sequences. New computational tools based onhaplotype inference of viral quasispecies were recently re-
leased and used successfully to construct haplotypes from
HIV-1 and hepatitis C virus populations [51,52]; it would
be of interest to evaluate their performance on an empir-
ical dataset as we have shown here.
Conclusions
We have demonstrated that BAsE-Seq successfully per-
forms single virion sequencing on HBV by generating viral
haplotypes longer than 3 kb, with substantially improved
accuracy in SNV calling compared with conventional deep
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computational or molecular-based methods to obtain viral
haplotypes is its high sensitivity and specificity. In a mixed
HBV clone sample, BAsE-Seq accurately assembled haplo-
types present at ≥0.4% frequency and achieved greater
than 99.9% specificity. In a clinical sample, a sub-genomic
haplotype present at approximately 0.08% frequency was
validated by clonal sequencing. Notably, we used BAsE-
Seq to obtain the first-time measurement of >9,000 viral
haplotypes in a clinical sample, which allowed us to evalu-
ate the intra-host population genetic structure of viral
quasispecies in a chronic infection and track the co-
occurrence of mutations located several kilobases apart
across hundreds of unique haplotypes. The method de-
scribed here is a significant improvement over existing
methods to characterize viral quasispecies and will provide
a useful tool to study the population genetic basis of viral
persistence in a wide range of infections.
Materials and methods
Ethics statement
All patients provided written informed consent accord-
ing to the Declaration of Helsinki, and the study proto-
cols were approved by the institutional review board of
the participating hospitals.
Hepatitis B virus clones
Viral DNA from a chronic hepatitis B patient was iso-
lated from 100 μl of serum using the QIAamp UltraSens
Virus kit (Qiagen, Venlo, Limburg, Netherlands). Full-
length HBV amplicons were obtained by PCR amplifica-
tion of 5 ng of viral DNA using previously published
primers [53], gel-purified using a MinElute Gel Extraction
kit (Qiagen), cloned into a pCR2.1-TOPO vector (Life
Technologies, Carlsbad, CA, USA), and transformed into
Escherichia coli ABLE K competent cells (Agilent, Santa
Clara, CA, USA) following the manufacturers’ protocols.
Purified clones were verified for the presence of an ap-
proximately 3.2 kb insert by PCR, and full-length sequen-
cing of the insert was performed using a primer walking
approach (Table S1 in Additional file 1). The sequencing
reactions were performed using a BIGDYE Terminator
v3.1 kit (Life Technologies) and loaded on a 3730xl instru-
ment (Life Technologies) for analysis. For BAsE-Seq li-
brary preparation, each HBV clone (Clone-1 and Clone-2)
was linearized by restriction digest with NotI (NEB,
Ipswich, MA, USA), gel-purified using a MinElute Gel
Extraction kit (Qiagen), quantified using a Qubit dsDNA BR
assay kit (Life Technologies), and diluted to 106 copies/μl.
Patient sample S7.1
S7.1 is a genotype B HBV sample that was isolated from
a chronic hepatitis B patient in 1990, and was selected
from a database of samples in which clonal sequencingof the precore/core region had been previously described
[54]. Briefly, viral DNA was isolated from 200 μl of
serum using the QIAamp DNA Blood Mini kit (Qiagen)
and nested PCR amplification was carried out on the
precore/core region. The 700-bp nested PCR product was
purified, cloned into a pGEM-T vector (Promega, Madison,
WI, USA), and transformed in E. coli JM109 cells (Promega).
Positive clones were sequenced using vector-specific
primers with BIGDYE Terminator on the 3730xl se-
quencer (Life Technologies). After quality trimming, a
466-bp region was obtained for each clone for further
analysis. Viral DNA from S7.1 was also used for Deep-Seq
and BAsE-Seq library preparation. To quantify the num-
ber of full-length genomes in the sample, real-time PCR
was performed using the EXPRESS SYBR GreenER qPCR
Supermix (Life Technologies) with primers (5′-ACTGTT
CAAGCCTCCAAGCTG-3′ and 5′-AAAAGTTGCATG
GTGCTGGTGA-3′) that amplified full-length amplicons
of the HBV genome. The sample was measured in tripli-
cate and its concentration was estimated by plotting the
Ct values against a standard curve that was generated
using a 10-fold dilution series of HBV Clone-2. 106 HBV
genomes from the sample were used for BAsE-Seq library
preparation.
BAsE-Seq library preparation
A detailed protocol, including oligonucleotide sequences, is
provided as Additional file 2. Using HBV-specific primers
that contain universal sequence on their 5′ ends, 106 HBV
genomes were uniquely assigned to a molecular barcode
(20 random nucleotides) by performing two cycles of PCR
using the Long PCR Enzyme Mix (Thermo Scientific,
Waltham, MA, USA). Excess primers were removed
by Exonuclease I (Enzymatics, Beverly, MA, USA). We
clonally amplified 40,000 copies of barcode-tagged ge-
nomes using the Long PCR Enzyme Mix (Thermo
Scientific) and universal primers, then digested with SbfI
(NEB) to protect the barcode-proximal end from exo-
nuclease digest. Next, unidirectional nested deletions
from the barcode-distal end were generated using a com-
bination of Exonuclease III and S1 Nuclease (Promega) to
achieve a broad size distribution of fragments ranging from
approximately 300 bp to 3,200 bp. Barcode-containing
fragments were purified using streptavidin-coated Dynabeads
(Life Technologies) and subjected to end repair using T4
DNA polymerase and T4 Polynucleotide Kinase (NEB).
End-repaired molecules were circularized by intramolecular
ligation using T4 DNA Ligase (NEB) and uncircularized mol-
ecules were removed by digestion with Lambda Exonuclease
and Exonuclease I (Enzymatics). After circularization, differ-
ent regions from each viral genome were juxtaposed with
the barcode assigned to that genome. The circularized
molecules were used as a template for random frag-
mentation and adapter tagging using the Nextera XT kit
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a set of custom primers was used to randomly incorporate
the ‘P5’ adapter and place the ‘P7’ adapter next to the
barcode. Each library was subjected to size selection to
remove fragments <400 bp using AMPure XP beads
(Beckman Coulter, Brea, CA, USA), verified on a Bioanalyzer
(Agilent), and quantified by real-time PCR using a Library
Quantification kit (KAPA Biosystems, Wilmington, MA,
USA). We loaded 18 pM of each library on a Miseq 300-
cycle reagent cartridge (Illumina) for 2 × 150 bp sequen-
cing. During sequencing, a custom sequencing primer that
annealed to the forward priming sequence of HBV was
used for the second read to ensure that it begins at the
barcode.
During library preparation for sample S7.1, barcodes
were separately assigned to patient-specific viral ge-
nomes and HBV Clone-2 (which we refer to as an 'in-
ternal standard'). The barcodes assigned to the internal
standard contain a two-base insertion that served to dis-
tinguish them from patient-specific barcodes. After bar-
coding, 5,000 copies of the internal standard were mixed
with 35,000 copies of patient-specific genomes and used
to build a BAsE-Seq library.
BAsE-Seq data analysis
Read pairs were trimmed to remove the barcode, univer-
sal and adapter sequences using Fastx (v0.0.13) and
Trimmomatic (v0.30). After trimming, read pairs that
were ≥15 bp in length were aligned to a 'bulk consensus'
genome using default parameters on the Burrows-Wheeler
Aligner (BWA; v0.6.1). The bulk consensus genome used
to analyze the mixed-clone libraries was the Clone-2 refer-
ence sequence obtained by Sanger sequencing. For pa-
tient sample S7.1, the bulk consensus genome was obtained
by first aligning reads using BWA against a genotype B
HBV reference sequence (GenBank accession number
AF121245.1) and extracting the major base call (or indel)
at each position. Then, reads were aligned to the newly
derived bulk consensus genome and the process was re-
peated iteratively until saturation was achieved with the
proportion of mapped reads. BAsE-Seq primers amplify
the HBV genomic region spanning base positions 42 to
3,156 and 39 to 3,219 on the Clone-2 and S7.1 consensus
genomes, respectively.
For 'bulk' data analysis, BAM files from concordantly
aligned reads (read 1: forward strand; read 2: reverse strand)
were used as input for variant calling using the -Q25 setting
(ignore non-reference bases <Q25) in LoFreq [40] (v2.0.0).
For 'individual' genome analysis, concordantly aligned
reads were de-multiplexed into individual genome BAM
files using the identity of the barcode associated with each
read pair. PCR duplicates associated with individual ge-
nomes were removed using the rmdup function in sam-
tools (v0.1.18) [55]. Next, vcf files were generated usingthe mpileup (-C50 -Q25 -d 1000 -DEu) function in sam-
tools (v0.1.18). An 'individual consensus' sequence was
obtained for each viral genome by extracting the consen-
sus base call at each position. Specifically, a consensus
base call was generated if the per-base coverage was ≥4
reads and the concordance was ≥0.7, that is, the major
base call occurred in at least 70% of reads. The number
of 'high quality genomes' extracted from each sample
will depend on the genome coverage threshold (Table S3
in Additional file 1). We used a higher genome coverage
threshold (85%) for the mixed clone libraries to maximize
the number of haplotypes with complete SNV calls and a
lower genome coverage threshold (50%) for the patient
sample to maximize the number of haplotypes recovered
for downstream analysis. SNVs - relative to the bulk
consensus genome - were identified from individual viral
genomes and filtered for those that occurred in ≥2 ge-
nomes in the sample and where base calls were gen-
erated in ≥1,500 genomes at that position. Finally,
haplotypes were constructed for each library using the
filtered SNVs.
To determine the library-specific error rate for S7.1, read
pairs associated with the internal standard were analyzed
separately from patient-specific reads. Errors in the in-
ternal standard - SNVs relative to the Clone-2 sequence -
were identified from individual viral genomes and filtered
for those where base calls were generated in ≥100 genomes
at that position. The highest per-base error observed in
the data was used to set the baseline error frequency for
SNVs observed in the patient sample. We defined this as
the frequency threshold below which the SNV might be
due to an error and above which the SNV is treated as a
true SNV.
To maximize the recovery of haplotype information, we
implemented a method to impute the identity of ambigu-
ous bases (Ns) in haplotypes that may arise as a result of
low per-base coverage or concordance. First, information
was shared across haplotypes using a conservative cluster-
ing approach. Haplotypes were clustered using a greedy
algorithm that sequentially builds a set of seeds (for clus-
ters) considering haplotypes in order of decreasing abun-
dance. Haplotypes that perfectly matched one of the
existing seeds (ignoring Ns) were clustered with them
and used to generate a consensus haplotype. Consen-
sus bases were determined by taking the most common
base if its frequency was at least 10% greater than the
next most common base and using an N otherwise.
Haplotypes with Ns in more than 10% of their bases
and less than two non-reference bases were excluded
from consideration as potential seeds and were reported
as singleton clusters.
Unless otherwise stated, custom perl and shell scripts
were used for data analysis and are available upon
request.
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Haplotypes with less than 10 Ns and count ≥10 were used
to construct a phylogenetic tree using MrBayes [56] (ver-
sion 3.2.2; consensus based on 10,000 sample trees, GTR
model, γ-distributed rate variation, burn-in of 100,000 it-
erations and sampling every 200 iterations) and plotted in
R using the Ape package [57].
Deep-Seq library preparation
HBV-specific primers (5′-GCTCTTCTTTTTCACCTCT
GCCTAATCA-3′ and 5′-GCTCTTCAAAAAGTTGCA
TGGTGCTGG-3′) were used to generate a full-length
amplicon of the HBV genome using the PfuUltra II
Fusion HS DNA Polymerase (Agilent) according to the
manufacturer’s instructions. The PCR product was run on
a 1% agarose gel and the approximately 3.2 kb frag-
ment was purified using the QIAquick Gel Extraction
Kit (Qiagen). The purified sample was sheared into 100
to 300 bp fragments using the following conditions on
the Covaris S2 (Covaris, Woburn, MA, USA): duty cycle,
20%; intensity, 5; cycles per burst, 200; time, 110 seconds.
The fragments were purified using the QIAquick PCR
purification kit (Qiagen) and a Deep-Seq library was pre-
pared using the KAPA Library Preparation Kit (KAPA
Biosystems) following the manufacturer’s instructions.
TruSeq adapters and dual-indexing primers (Illumina)
were used for library preparation and the final PCR
step was performed using PfuUltra II Fusion HS DNA
Polymerase according to the manufacturer’s instructions.
The library was quantified by real-time PCR using a
Library Quantification kit (KAPA Biosystems) and loaded
on a flowcell for 2 × 101 bp sequencing on a HiSeq 2500
(Illumina).
Deep-Seq data analysis
The essential steps in our data analysis pipeline follow
the protocol described in Aw et al. [39]. In brief, a con-
sensus sequence for the sample was obtained by iterative
alignment of the sequence reads against a reference
using BWA (as described above). After the final map-
ping, SNVs were identified using LoFreq [40] (v2.0.0)
and variants within the primer region (base positions 1
to 21 and 3201 to 3220) were removed.
Data availability
Raw data have been deposited in the NCBI Sequence
Read Archive under accession number PRJNA251790.Additional files
Additional file 1: Figure S1. Barcode assignment and error removal.
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sample by BAsE-Seq. Table S4. True SNVs identified by BAsE-Seq in S7.1.
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